News for hackers. Stuff that matters.
Re:The Unreasonable Math of Type 1 Diabetes by kakoni on Friday February 18, 2022 @03:15AM (#30383307)
+ the funny thing is that both openaps/androids + loopkit are more advanced than the commercial offerings that we are starting to see now.

Medtronic licensed their artificial pancreas system MD-Logic from Israeli company DreaMed in 2015. Dexcom bought TypeZero (who have system called inControl) back in 2018.

Re:The Unreasonable Math of Type 1 Diabetes by jacquesm on Friday February 18, 2022 @09:14AM (#30385871)
That's to be expected though, self experimentation goes a lot quicker than a regulated track. Even so they are doing great work, and I'm sure the industry is watching this development like a hawk to see what they can pick up.